Ovarian Cancer
📧 Sign up to get email alerts when something new happens for Ovarian Cancer.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2013-06-07Clinical Trial Update: Study of Drug to Reduce Thrombocytopenia in Patients Receiving Chemo for Ovarian, Fallopian Tube or Peritoneal Cancer [Phase 2]
Phase 2 trial of an investigational Tarix Pharmaceuticals agent to reduce chemotherapy-induced thrombocytopenia in patients with ovarian, fa…
-
CLINICAL_TRIALS trial_result · 2013-06-05Clinical Trial Update: Temozolomide in Treating Patients With Metastatic Germ Cell Tumors That Have Not Responded to Cisplatin [Phase 2]
Phase 2 trial of temozolomide in patients with metastatic germ cell tumors that did not respond to cisplatin has been completed.
-
CLINICAL_TRIALS trial_result · 2013-06-05Clinical Trial Update: Monoclonal Antibody Vaccine Therapy in Treating Patients With Ovarian Epithelial, Fallopian Tube, or Peritoneal Cancer [Phase 1]
Phase 1 trial evaluating a monoclonal antibody vaccine therapy for ovarian epithelial, fallopian tube, and primary peritoneal cancers has co…
-
CLINICAL_TRIALS trial_result · 2013-06-05Clinical Trial Update: A Pilot Test for Newly Developed Synoptic Operative Template for Ovarian Cancer (SOTOC): National Cancer Center - Peritoneal Carcinomatosis Index
This is a pilot test of a synoptic operative template for ovarian cancer using the Peritoneal Carcinomatosis Index, sponsored by the Nationa…
-
CLINICAL_TRIALS trial_result · 2013-06-04Clinical Trial Update: Efficacy and Safety of Pazopanib Monotherapy After First-line Chemotherapy in Ovarian, Fallopian Tube, or Primary Peritoneal Cancer in Asian Women [Phase 2]
A Phase 2 trial evaluating pazopanib monotherapy after first-line chemotherapy in Asian women with ovarian, fallopian tube, or primary perit…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2013-06-04Clinical Trial Update: Interleukin-12, Paclitaxel, and Trastuzumab in Treating Patients With Solid Tumors [Phase 1]
Phase 1 trial evaluating the safety and preliminary activity of combining interleukin-12, paclitaxel, and trastuzumab in patients with vario…
-
CLINICAL_TRIALS trial_result · 2013-06-03Clinical Trial Update: Preference Study With Elderly Patients Recurrent Ovarian Cancer [Phase 3]
A Phase 3 preference study in elderly patients with recurrent ovarian cancer has completed.
-
CLINICAL_TRIALS trial_result · 2013-05-30Clinical Trial Update: Combination Chemotherapy and Bone Marrow Transplant in Treating Patients With Refractory or Recurrent Ovarian Cancer [Phase 2]
This document provides an update on a Phase 2 trial evaluating the combination chemotherapy with bone marrow transplantation in patients wit…
-
CLINICAL_TRIALS trial_result · 2013-05-30Clinical Trial Update: CT-2103 in Treating Patients With Recurrent Ovarian Epithelial or Fallopian Tube Cancer or Primary Peritoneal Cancer [Phase 1, Phase 2]
A Phase 1/2 clinical trial (CT-2103) evaluated CT-2103 in patients with recurrent ovarian epithelial cancer, fallopian tube cancer, or prima…
-
CLINICAL_TRIALS trial_result · 2013-05-27Clinical Trial Update: Gemcitabine Plus Cisplatin in Treating Patients With Ovarian Epithelial Cancer or Primary Peritoneal Cancer That Is Recurrent or Has Not Responded to Platinum-based Chemotherapy [Phase 2]
Phase 2 clinical trial evaluating the combination of gemcitabine and cisplatin for patients with recurrent or platinum-refractory ovarian ca…
-
CLINICAL_TRIALS trial_result · 2013-05-27Clinical Trial Update: Paclitaxel and Cisplatin in Treating Patients With Stage III or Stage IV Ovarian Cancer or Primary Peritoneal Cancer [Phase 3]
This clinical trial update reports the completion of a Phase 3 study evaluating paclitaxel plus cisplatin in patients with stage III or IV o…
-
CLINICAL_TRIALS trial_result · 2013-05-27Clinical Trial Update: Paclitaxel in Treating Patients With Recurrent or Persistent Ovarian or Primary Peritoneal Cancer [Phase 1]
This update summarizes a Phase 1 clinical trial evaluating paclitaxel in patients with recurrent or persistent ovarian cancer or primary per…
-
CLINICAL_TRIALS trial_result · 2013-05-27Clinical Trial Update: Topotecan Plus Etoposide in Treating Patients With Recurrent Ovarian, Peritoneal, or Fallopian Tube Cancer [Phase 1]
Phase 1 trial evaluating the combination of topotecan and etoposide in patients with recurrent ovarian, fallopian tube, or primary peritonea…
-
CLINICAL_TRIALS trial_result · 2013-05-27Clinical Trial Update: Combination Chemotherapy in Treating Patients With Stage III or Stage IV Ovarian Epithelial or Primary Peritoneal Cancer [Phase 1]
A Phase 1 study of a combination chemotherapy regimen for stage III/IV ovarian epithelial cancer or primary peritoneal cancer has completed.
-
CLINICAL_TRIALS trial_result · 2013-05-27Clinical Trial Update: Quality of Life in Survivors of Gynecologic Cancer
This completed clinical trial update reports on quality of life outcomes among survivors of gynecologic cancers, specifically endometrial an…
-
CLINICAL_TRIALS trial_result · 2013-05-27Clinical Trial Update: Combination Chemotherapy in Treating Patients With Untreated Ovarian, Peritoneal, or Fallopian Tube Cancer [Phase 1]
This is a Phase 1 study of a combination chemotherapy regimen in patients with untreated ovarian cancer, fallopian tube cancer, or primary p…
-
CLINICAL_TRIALS trial_result · 2013-05-27Clinical Trial Update: Combination Chemotherapy in Treating Patients With Primary Peritoneal or Stage III Epithelial Ovarian Cancer [Phase 3]
A Phase 3 trial evaluating a combination chemotherapy regimen for stage III epithelial ovarian cancer and primary peritoneal cancer has comp…
-
CLINICAL_TRIALS trial_result · 2013-05-21Clinical Trial Update: Bevacizumab Plus Gemcitabine, Docetaxel, Melphalan, and Carboplatin in Ovarian Cancer Patients [Phase 2]
Phase 2 trial evaluating bevacizumab with gemcitabine, docetaxel, melphalan, and carboplatin in ovarian cancer; the study was terminated and…
-
CLINICAL_TRIALS trial_result · 2013-05-16Clinical Trial Update: Abraxane/Bevacizumab [Phase 2]
A Phase 2 trial of Abraxane (nab-paclitaxel) in combination with Bevacizumab for ovarian cancer and peritoneal cancer was terminated, with r…
-
CLINICAL_TRIALS trial_result · 2013-05-14Clinical Trial Update: Cisplatin and Flavopiridol in Treating Patients With Advanced Ovarian Epithelial Cancer or Primary Peritoneal Cancer [Phase 2]
Phase 2 trial evaluating cisplatin in combination with flavopiridol for advanced or recurrent ovarian epithelial cancer and recurrent primar…
-
CLINICAL_TRIALS trial_result · 2013-05-14Clinical Trial Update: A Study of ZYC300 Administered With Cyclophosphamide Pre-Dosing [Phase 1]
A Phase 1 study of ZYC300 with cyclophosphamide pre-dosing has completed, evaluating its use in breast cancer and ovarian cancer.
-
CLINICAL_TRIALS trial_result · 2013-05-13Clinical Trial Update: A Study of Carboplatin/Paclitaxel With Pegfilgrastim Supported by Haematopoietic Progenitor Cell Re-Infusion in Whole Blood [Phase 2]
Phase 2 trial evaluating carboplatin/paclitaxel with pegfilgrastim supported by hematopoietic progenitor cell re-infusion in whole blood in …
-
CLINICAL_TRIALS trial_result · 2013-05-07Clinical Trial Update: Distinction Between Lung Cancer and Gynecological Cancers by Canine Scent Detection [Phase 2]
Phase 2 trial investigating canine scent detection to distinguish lung cancer from gynecological cancers has been terminated.
-
CLINICAL_TRIALS trial_result · 2013-04-26Clinical Trial Update: Phase I/II Study of Escalating-Dose Melphalan w/Autologous SCS & Amifostine Cytoprotect [Phase 1, Phase 2]
Phase I/II clinical trial updating escalating-dose melphalan with autologous stem cell support and amifostine cytoprotection across multiple…
-
CLINICAL_TRIALS trial_result · 2013-04-18Clinical Trial Update: Prostaglandin Metabolite in Urine Samples From Patients With Ovarian Cancer
This clinical trial update presents results from a study examining prostaglandin metabolites in urine samples from patients with ovarian can…